ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 3,332,616 | $10,431,000 | 2.35% |
Think Investments LP | 2,000,000 | $6,260,000 | 1.16% |
RTW INVESTMENTS, LP | 5,978,355 | $18,712,000 | 0.45% |
COWEN AND COMPANY, LLC | 472,649 | $1,479,000 | 0.24% |
CADENCE CAPITAL MANAGEMENT LLC | 50,736 | $159,000 | 0.04% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 41,700 | $131,000 | 0.04% |
Hudson Bay Capital Management LP | 710,000 | $2,222,000 | 0.03% |
Ikarian Capital, LLC | 115,000 | $360,000 | 0.03% |
MIRABELLA FINANCIAL SERVICES LLP | 52,892 | $166,000 | 0.02% |
Secure Asset Management, LLC | 10,000 | $31,000 | 0.02% |